Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Reexamination Certificate
2006-05-02
2006-05-02
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
Reexamination Certificate
active
07037905
ABSTRACT:
Use of compounds to inhibit hormone-sensitive lipase, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds, method of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of a range of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
REFERENCES:
patent: 5312816 (1994-05-01), Spielvogel et al.
patent: 6075014 (2000-06-01), Weston et al.
patent: 6267952 (2001-07-01), Mandeville, III et al.
patent: 2002/0128232 (2002-09-01), Henderson et al.
patent: 2003/0064963 (2003-04-01), Holmes-Farley et al.
patent: 792883 (1997-03-01), None
patent: 2758329 (1997-01-01), None
patent: WO 98/31688 (1998-07-01), None
Ebdrup Soren
Jacobsen Poul
Vedso Per
Bork Richard W.
Green Reza
Henley III Raymond J.
Novo Nordisk A S
Wilk-Orescan Rosemarie R.
LandOfFree
Pharmaceutical use of boronic acids and esters thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical use of boronic acids and esters thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical use of boronic acids and esters thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3608621